메뉴 건너뛰기




Volumn 38, Issue 8 SUPPL., 2010, Pages

Recognition and prevention of multidrug-resistant Gram-negative bacteria in the intensive care unit

Author keywords

antimicrobial resistance; Gram negative bacteria; healthcare associated infections; infection control; intensive care unit; multidrug resistant; prevention

Indexed keywords

CARBAPENEMASE; COLISTIN;

EID: 77954939129     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181e6cbc5     Document Type: Article
Times cited : (55)

References (55)
  • 1
    • 42549108748 scopus 로고    scopus 로고
    • Acinetobacter bau-mannii: Epidemiology, antimicrobial resistance, and treatment options
    • Maragakis LL, Perl TM: Acinetobacter bau-mannii: Epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46:1254-1263
    • (2008) Clin Infect Dis , vol.46 , pp. 1254-1263
    • Maragakis, L.L.1    Perl, T.M.2
  • 2
    • 58149240183 scopus 로고    scopus 로고
    • Carbapenem-resistant Enterobacteriaceae: A potential threat
    • Schwaber MJ, Carmeli Y: Carbapenem-resistant Enterobacteriaceae: A potential threat. JAMA 2008; 300(24):2911-2913
    • (2008) JAMA , vol.300 , Issue.24 , pp. 2911-2913
    • Schwaber, M.J.1    Carmeli, Y.2
  • 3
    • 0035871033 scopus 로고    scopus 로고
    • Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneu-moniae: Risk factors for infection and impact of resistance on outcomes
    • Lautenbach E, Patel JB, Bilker WB, et al: Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneu-moniae: Risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32:1162-1171
    • (2001) Clin Infect Dis , vol.32 , pp. 1162-1171
    • Lautenbach, E.1    Patel, J.B.2    Bilker, W.B.3
  • 4
    • 22144433025 scopus 로고    scopus 로고
    • Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-produc-ing Enterobacteriaceae: Variability by site of infection
    • Hyle EP, Lipworth AD, Zaoutis TE, et al: Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-produc-ing Enterobacteriaceae: Variability by site of infection. Arch Intern Med 2005; 165: 1375-1380
    • (2005) Arch Intern Med , vol.165 , pp. 1375-1380
    • Hyle, E.P.1    Lipworth, A.D.2    Zaoutis, T.E.3
  • 5
    • 30144434179 scopus 로고    scopus 로고
    • Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: Maximizing clinical outcomes and minimizing selection of resistant organisms
    • Niederman MS: Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: Maximizing clinical outcomes and minimizing selection of resistant organisms. Clin Infect Dis 2006; 42(Suppl 2):S72-S81
    • (2006) Clin Infect Dis , vol.42 , Issue.SUPPL. 2
    • Niederman, M.S.1
  • 6
    • 25444451566 scopus 로고    scopus 로고
    • Et al Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: The role of inadequate empirical antimicrobial therapy
    • Lautenbach E, Metlay JP, Bilker WB, et al Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: The role of inadequate empirical antimicrobial therapy. Clin Infect Dis 2005; 41:923-929
    • (2005) Clin Infect Dis , vol.41 , pp. 923-929
    • Lautenbach, E.1    Metlay, J.P.2    Bilker, W.B.3
  • 7
    • 0037185447 scopus 로고    scopus 로고
    • Health and economic outcomes of the emergence of third-generation cephalospo-rin resistance in Enterobacter species
    • Cosgrove SE, Kaye KS, Eliopoulous GM, et al: Health and economic outcomes of the emergence of third-generation cephalospo-rin resistance in Enterobacter species. Arch Intern Med 2002; 162:185-190
    • (2002) Arch Intern Med , vol.162 , pp. 185-190
    • Cosgrove, S.E.1    Kaye, K.S.2    Eliopoulous, G.M.3
  • 8
    • 0033599982 scopus 로고    scopus 로고
    • Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
    • Carmeli Y, Troillet N, Karchmer AW, et al: Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999; 159:1127-1132
    • (1999) Arch Intern Med , vol.159 , pp. 1127-1132
    • Carmeli, Y.1    Troillet, N.2    Karchmer, A.W.3
  • 9
    • 33747362870 scopus 로고    scopus 로고
    • Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
    • Li J, Nation RL, Turnidge JD, et al: Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006; 6:589-601
    • (2006) Lancet Infect Dis , vol.6 , pp. 589-601
    • Li, J.1    Nation, R.L.2    Turnidge, J.D.3
  • 10
    • 36448983944 scopus 로고    scopus 로고
    • Poly-myxin B for the treatment of multidrug-resistant pathogens: A critical review
    • Zavascki AP, Goldani LZ, Li J, et al: Poly-myxin B for the treatment of multidrug-resistant pathogens: A critical review. J An-timicrob Chemother 2007; 60:1206-1215
    • (2007) J An-timicrob Chemother , vol.60 , pp. 1206-1215
    • Zavascki, A.P.1    Goldani, L.Z.2    Li, J.3
  • 11
    • 29944446141 scopus 로고    scopus 로고
    • Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
    • Aloush V, Navon-Venezia S, Seigman-Igra Y, et al: Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact. Antimicrob Agents Chemother 2006; 50: 43-48
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 43-48
    • Aloush, V.1    Navon-Venezia, S.2    Seigman-Igra, Y.3
  • 12
    • 33646912478 scopus 로고    scopus 로고
    • Fluoroquinolone-resistant Pseudomonas aeruginosa: Assessment of risk factors and clinical impact
    • Gasink LB, Fishman NO, Weiner MG, et al: Fluoroquinolone-resistant Pseudomonas aeruginosa: Assessment of risk factors and clinical impact. Am J Med 2006; 119: 526-1525
    • (2006) Am J Med , vol.119 , pp. 526-1525
    • Gasink, L.B.1    Fishman, N.O.2    Weiner, M.G.3
  • 13
    • 33749028483 scopus 로고    scopus 로고
    • Imipenem resistance among Pseudomo-nas aeruginosa isolates: Risk factors for infection and impact of resistance on clinical and economic outcomes
    • Lautenbach E, Weiner MG, Nachamkin I, et al: Imipenem resistance among Pseudomo-nas aeruginosa isolates: Risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol 2006; 27:893-900
    • (2006) Infect Control Hosp Epidemiol , vol.27 , pp. 893-900
    • Lautenbach, E.1    Weiner, M.G.2    Nachamkin, I.3
  • 14
    • 33846116186 scopus 로고    scopus 로고
    • Multidrug-resistant Acinetobacter infection mortality rate and length of hospital-ization
    • Sunenshine RH, Wright MO, Maragakis LL, et al: Multidrug-resistant Acinetobacter infection mortality rate and length of hospital-ization. Emerg Infect Dis 2007; 13:97-103
    • (2007) Emerg Infect Dis , vol.13 , pp. 97-103
    • Sunenshine, R.H.1    Wright, M.O.2    Maragakis, L.L.3
  • 15
    • 34248208644 scopus 로고    scopus 로고
    • Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
    • Kwon KT, Oh WS, Song JH, et al: Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimi-crob Chemother 2007; 59:525-530
    • (2007) J Antimi-crob Chemother , vol.59 , pp. 525-530
    • Kwon, K.T.1    Oh, W.S.2    Song, J.H.3
  • 16
    • 35348890215 scopus 로고    scopus 로고
    • Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes
    • Abbo A, Carmeli Y, Navon-Venezia S, et al: Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 2007; 26:793-800
    • (2007) Eur J Clin Microbiol Infect Dis , vol.26 , pp. 793-800
    • Abbo, A.1    Carmeli, Y.2    Navon-Venezia, S.3
  • 17
    • 33144460009 scopus 로고    scopus 로고
    • The epidemiology and control of Acinetobacter baumannii in health care facilities
    • Fournier PE, Richet H: The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42:692-699
    • (2006) Clin Infect Dis , vol.42 , pp. 692-699
    • Fournier, P.E.1    Richet, H.2
  • 18
    • 19944421444 scopus 로고    scopus 로고
    • Predictors of mortality in Acinetobacter baumannii bacteremia
    • Chen HP, Chen TL, Lai CH, et al: Predictors of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2005; 38:127-136
    • (2005) J Microbiol Immunol Infect , vol.38 , pp. 127-136
    • Chen, H.P.1    Chen, T.L.2    Lai, C.H.3
  • 19
    • 0037352118 scopus 로고    scopus 로고
    • Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: A matched cohort study
    • Blot S, Vandewoude K, Colardyn F: Nosoco-mial bacteremia involving Acinetobacter baumannii in critically ill patients: A matched cohort study. Intensive Care Med 2003; 29:471-475 (Pubitemid 36379452)
    • (2003) Intensive Care Medicine , vol.29 , Issue.3 , pp. 471-475
    • Blot, S.1    Vandewoude, K.2    Colardyn, F.3
  • 20
    • 73449096797 scopus 로고    scopus 로고
    • Risk factors and clinical impact of Kleb-siella pneumoniae carbapenemase-produc-ing K. pneumoniae
    • Gasink LB, Edelstein PH, Lautenbach E, et al: Risk factors and clinical impact of Kleb-siella pneumoniae carbapenemase-produc-ing K. pneumoniae. Infect Control Hosp Epidemiol 2009; 30:1180-1185
    • (2009) Infect Control Hosp Epidemiol , vol.30 , pp. 1180-1185
    • Gasink, L.B.1    Edelstein, P.H.2    Lautenbach, E.3
  • 21
    • 62749131175 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention: Guidance for control of infections with car-bapenem-resistant or carbapenemase-pro-ducing Enterobacteriaceae in acute care facilities
    • Centers for Disease Control and Prevention: Guidance for control of infections with car-bapenem-resistant or carbapenemase-pro-ducing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009; 58:256-260
    • (2009) MMWR Morb Mortal Wkly Rep , vol.58 , pp. 256-260
  • 22
    • 72249087115 scopus 로고    scopus 로고
    • International study of the prevalence and outcomes of infection in intensive care units
    • Vincent JL, Rello J, Marshall J, et al: International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-2329
    • (2009) JAMA , vol.302 , pp. 2323-2329
    • Vincent, J.L.1    Rello, J.2    Marshall, J.3
  • 23
    • 71449094486 scopus 로고    scopus 로고
    • National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009
    • Edwards JR, Peterson KD, Mu Y, et al: National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37:783-805
    • (2009) Am J Infect Control , vol.37 , pp. 783-805
    • Edwards, J.R.1    Peterson, K.D.2    Mu, Y.3
  • 24
    • 54949148412 scopus 로고    scopus 로고
    • NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
    • Hidron AI, Edwards JR, Patel J, et al: NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996-1011
    • (2008) Infect Control Hosp Epidemiol , vol.29 , pp. 996-1011
    • Hidron, A.I.1    Edwards, J.R.2    Patel, J.3
  • 25
    • 77951034298 scopus 로고    scopus 로고
    • Multidrug resistance among Gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008
    • Kallen AJ, Hidron AI, Patel J, et al: Multidrug resistance among Gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2010; 31:528-531
    • (2010) Infect Control Hosp Epidemiol , vol.31 , pp. 528-531
    • Kallen, A.J.1    Hidron, A.I.2    Patel, J.3
  • 26
    • 33747604662 scopus 로고    scopus 로고
    • What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?
    • Harris AD, McGregor JC, Furuno JP: What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006; 43(Suppl 2):S57-S61
    • (2006) Clin Infect Dis , vol.43 , Issue.SUPPL. 2
    • Harris, A.D.1    McGregor, J.C.2    Furuno, J.P.3
  • 27
    • 77951251859 scopus 로고    scopus 로고
    • Treatment with fluoroquinolones or with beta-lactam/beta-lactamase inhibitor combinations are risk factors for the isolation of extended-spectrum {beta}-lactamase-producing Klebsiella species in hospitalized patients
    • Wener KM, Schechner V, Gold HS, et al: Treatment with fluoroquinolones or with beta-lactam/beta-lactamase inhibitor combinations are risk factors for the isolation of extended-spectrum {beta}-lactamase-producing Klebsiella species in hospitalized patients. Antimicrob Agents Chemother. 2010; 54(5):2010-2016
    • (2010) Antimicrob Agents Chemother. , Issue.5 , pp. 2010-2016
    • Wener, K.M.1    Schechner, V.2    Gold, H.S.3
  • 28
    • 9144232354 scopus 로고    scopus 로고
    • International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial Infections
    • Paterson DL, Ko WC, Von Gottberg A, et al: International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004; 140:26-32
    • (2004) Ann Intern Med , vol.140 , pp. 26-32
    • Paterson, D.L.1    Ko, W.C.2    Von Gottberg, A.3
  • 29
    • 0142252609 scopus 로고    scopus 로고
    • Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: A case-control study in a district teaching hospital in Taiwan
    • Lin MF, Huang ML, Lai SH: Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: A case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003; 53:39-45
    • (2003) J Hosp Infect , vol.53 , pp. 39-45
    • Lin, M.F.1    Huang, M.L.2    Lai, S.H.3
  • 30
    • 0033979735 scopus 로고    scopus 로고
    • Outbreak of a multiresistant Klebsiella pneu-moniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection
    • Asensio A, Oliver A, Gonzalez-Diego P, et al: Outbreak of a multiresistant Klebsiella pneu-moniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000; 30:55-60
    • (2000) Clin Infect Dis , vol.30 , pp. 55-60
    • Asensio, A.1    Oliver, A.2    Gonzalez-Diego, P.3
  • 31
    • 33847027647 scopus 로고    scopus 로고
    • Carbap-enem-resistant Acinetobacter baumannii in intensive care unit patients: Risk factors for acquisition, infection and their consequences
    • Playford EG, Craig JC, Iredell JR: Carbap-enem-resistant Acinetobacter baumannii in intensive care unit patients: Risk factors for acquisition, infection and their consequences. J Hosp Infect 2007; 65:204-211
    • (2007) J Hosp Infect , vol.65 , pp. 204-211
    • Playford, E.G.1    Craig, J.C.2    Iredell, J.R.3
  • 32
    • 67651085441 scopus 로고    scopus 로고
    • Carbapenem resistance among Klebsiella pneumoniae isolates: Risk factors, molecular characteristics, and susceptibility patterns
    • Hussein K, Sprecher H, Mashiach T, et al: Carbapenem resistance among Klebsiella pneumoniae isolates: Risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009; 30: 666-671
    • (2009) Infect Control Hosp Epidemiol , vol.30 , pp. 666-671
    • Hussein, K.1    Sprecher, H.2    Mashiach, T.3
  • 33
    • 0037097507 scopus 로고    scopus 로고
    • Control-group selection importance in studies of antimicrobial resistance: Examples applied to Pseudomonas aeruginosa, entero-cocci, and Escherichia coli
    • Harris AD, Samore MH, Lipsitch M, et al: Control-group selection importance in studies of antimicrobial resistance: Examples applied to Pseudomonas aeruginosa, entero-cocci, and Escherichia coli. Clin Infect Dis 2002; 34:1558-1563
    • (2002) Clin Infect Dis , vol.34 , pp. 1558-1563
    • Harris, A.D.1    Samore, M.H.2    Lipsitch, M.3
  • 34
    • 13644269309 scopus 로고    scopus 로고
    • And Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
    • American Thoracic Society
    • American Thoracic Society and Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 388-416
  • 35
    • 77954649852 scopus 로고    scopus 로고
    • Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission
    • Nseir S, Grailles G, Soury-Lavergne A, et al: Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. Clin Microbiol Infect 2010; 16:902-908
    • (2010) Clin Microbiol Infect , vol.16 , pp. 902-908
    • Nseir, S.1    Grailles, G.2    Soury-Lavergne, A.3
  • 36
    • 0003457567 scopus 로고    scopus 로고
    • 2009 Performance Standards for Antimicrobial Susceptibility Testing
    • Clinical and Laboratory Standards Institute Wayne, PA, Clinical and Laboratory Standards Institute
    • Clinical and Laboratory Standards Institute: 2009 Performance Standards for Antimicrobial Susceptibility Testing. 19th Information Supplement (M100-S19). Wayne, PA, Clinical and Laboratory Standards Institute, 2009
    • (2009) 19th Information Supplement (M100-S19)
  • 38
    • 77249160678 scopus 로고    scopus 로고
    • Systematic review of studies on compliance with hand hygiene guidelines in hospital care
    • Erasmus V, Daha TJ, Brug H, et al: Systematic review of studies on compliance with hand hygiene guidelines in hospital care. Infect Control Hosp Epidemiol 2010; 31:283-294
    • (2010) Infect Control Hosp Epidemiol , vol.31 , pp. 283-294
    • Erasmus, V.1    Daha, T.J.2    Brug, H.3
  • 39
    • 10844280035 scopus 로고    scopus 로고
    • An outbreak of multidrug-resistant Acineto-bacter baumannii associated with pulsatile lavage wound treatment
    • Maragakis LL, Cosgrove SE, Song X, et al: An outbreak of multidrug-resistant Acineto-bacter baumannii associated with pulsatile lavage wound treatment. JAMA 2004; 292: 3006-3011
    • (2004) JAMA , vol.292 , pp. 3006-3011
    • Maragakis, L.L.1    Cosgrove, S.E.2    Song, X.3
  • 40
    • 0036479514 scopus 로고    scopus 로고
    • Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units
    • Das I, Lambert P, Hill D, et al: Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect 2002; 50:110-114
    • (2002) J Hosp Infect , vol.50 , pp. 110-114
    • Das, I.1    Lambert, P.2    Hill, D.3
  • 41
    • 33747656337 scopus 로고    scopus 로고
    • Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation
    • Wilks M, Wilson A, Warwick S, et al: Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006; 27:654-658
    • (2006) Infect Control Hosp Epidemiol , vol.27 , pp. 654-658
    • Wilks, M.1    Wilson, A.2    Warwick, S.3
  • 42
    • 77949556977 scopus 로고    scopus 로고
    • Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant
    • Doidge M, Allworth AM, Woods M, et al: Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant. Infect Control Hosp Epidemiol 2010; 31:418-420
    • (2010) Infect Control Hosp Epidemiol , vol.31 , pp. 418-420
    • Doidge, M.1    Allworth, A.M.2    Woods, M.3
  • 43
    • 0031808598 scopus 로고    scopus 로고
    • Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates
    • Jawad A, Seifert H, Snelling AM, et al: Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates. J Clin Microbiol 1998; 36:1938-1941
    • (1998) J Clin Microbiol , vol.36 , pp. 1938-1941
    • Jawad, A.1    Seifert, H.2    Snelling, A.M.3
  • 45
    • 0037448354 scopus 로고    scopus 로고
    • An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes
    • Srinivasan A, Wolfenden LL, Song X, et al: An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med 2003; 348:221-227
    • (2003) N Engl J Med , vol.348 , pp. 221-227
    • Srinivasan, A.1    Wolfenden, L.L.2    Song, X.3
  • 47
    • 0037083034 scopus 로고    scopus 로고
    • Nosoco-mial antibiotic resistance in multiple Gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites
    • Rahal JJ, Urban C, Segal-Maurer S: Nosoco-mial antibiotic resistance in multiple Gram-negative species: Experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis 2002; 34: 499-503
    • (2002) Clin Infect Dis , vol.34 , pp. 499-503
    • Rahal, J.J.1    Urban, C.2    Segal-Maurer, S.3
  • 48
    • 70049084153 scopus 로고    scopus 로고
    • Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting
    • Gottesman BS, Carmeli Y, Shitrit P, et al: Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009; 49:869-875
    • (2009) Clin Infect Dis , vol.49 , pp. 869-875
    • Gottesman, B.S.1    Carmeli, Y.2    Shitrit, P.3
  • 49
    • 44649173118 scopus 로고    scopus 로고
    • Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures
    • Maragakis LL, Tucker MG, Miller RG, et al: Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008; 299: 2513-2514
    • (2008) JAMA , vol.299 , pp. 2513-2514
    • Maragakis, L.L.1    Tucker, M.G.2    Miller, R.G.3
  • 50
    • 77949565095 scopus 로고    scopus 로고
    • Natural history of colonization with Gram-negative multidrug-resistant organisms among hospitalized patients
    • Weintrob AC, Roediger MP, Barber M, et al: Natural history of colonization with Gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010; 31:330-337
    • (2010) Infect Control Hosp Epidemiol , vol.31 , pp. 330-337
    • Weintrob, A.C.1    Roediger, M.P.2    Barber, M.3
  • 51
    • 57749107808 scopus 로고    scopus 로고
    • Bad bugs no drugs No ESKAPE! An update from the Infectious Diseases Society of America
    • Boucher HW, Talbot GH, Bradley JS, et al: Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1-12
    • (2009) Clin Infect Dis , vol.48 , pp. 1-12
    • Boucher, H.W.1    Talbot, G.H.2    Bradley, J.S.3
  • 52
    • 67749145541 scopus 로고    scopus 로고
    • Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria
    • Plachouras D, Karvanen M, Friberg LE, et al: Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrob Agents Che-mother 2009; 53:3430-3436
    • (2009) Antimicrob Agents Che-mother , vol.53 , pp. 3430-3436
    • Plachouras, D.1    Karvanen, M.2    Friberg, L.E.3
  • 53
    • 67449090359 scopus 로고    scopus 로고
    • Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: Intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
    • Roberts JA, Kirkpatrick CMJ, Roberts MS, et al: Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: Intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J An-timicrob Chemother 2009; 64:142-150
    • (2009) J An-timicrob Chemother , vol.64 , pp. 142-150
    • Roberts, J.A.1    Cmj, K.2    Roberts, M.S.3
  • 54
    • 66449092115 scopus 로고    scopus 로고
    • A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics
    • Roberts JA, Webb S, Paterson D, et al: A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med 2009; 37: 2071-2078
    • (2009) Crit Care Med , vol.37 , pp. 2071-2078
    • Roberts, J.A.1    Webb, S.2    Paterson, D.3
  • 55
    • 75949106980 scopus 로고    scopus 로고
    • Research Committee of the Society for Healthcare Epidemiology of America: Enhancing patient safety by reducing healthcare-associated infections: The role of discovery and dissemination
    • Research Committee of the Society for Healthcare Epidemiology of America: Enhancing patient safety by reducing healthcare-associated infections: The role of discovery and dissemination. Infect Control Hosp Epidemiol 2010; 31:118-123
    • (2010) Infect Control Hosp Epidemiol , vol.31 , pp. 118-123


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.